{"url_path":"/sec/bpth/8-k/2026-07-16/item-8-01","section_key":"item-8-01","section_title":"Item 8.1 Other Events.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-16","source_url":"https://www.sec.gov/Archives/edgar/data/1133818/0001663577-26-000218-index.html","accession_number":"0001663577-26-000218","cik":"0001133818","ticker":"BPTH","issuer_name":"BIO-PATH HOLDINGS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1133818/0001663577-26-000218-index.html","primary_entity_key":"0001133818","primary_entity_name":"BIO-PATH HOLDINGS, INC."},"word_count":948,"has_tables":true,"body_markdown":"** **\n\n**Item 8.1 Other Events.**\n\n \n\nOn June 5, 2026, UT MD Anderson cancer center\n(“MDA” @ https://www.mdanderson.org/) agreed to restart our Phase 2 trials targeting acute myeloid leukemia  (AML) subject\nto us bringing them current on monies due of $292,264.21 for BP1001-201-AML and $63,286.55 for BP1002-201-AML. We believe the BP1001-201-AML\nPhase 2 trial will remain randomized using MDA to complete the final segment of the trial and can be restarted using a combination of\ncash from outside investors under our Tier 1 Regulation A offering and federal grants, which we intend to pursue through consultants.\n\n \n\nOn June 26, 2026, we opened a business account\nwith Coinbase Global (NASDAQ: COIN) to manage our recently launched AI-driven digital asset treasury targeting L1 and L2 coins and altcoins.\nWe intend to allocate up to 50% of capital raised to crypto opportunities.\n\n \n\nOn July 3, 2026, we engaged Farrington Capital\nGroup LLC (“FCG” @ https://farringtoncapitalgroup.com/), a strategic advisory firm focused on education, biotech, and real\nestate, to identify and close a strategic investor, buyer, JV partner and/or licensor for our biotechnology and intellectual property\nincluding our multiple Phase 1 and Phase 2 drug trials targeting blood cancer, solid tumors, obesity and other domains. We agreed to provide\nFCG a 60-day period of exclusivity to move discussions ahead with at least one candidate they have identified. Any fees will be success-based\nand there were no shares or cash issued as a retainer. There can be no assurances any transaction will be completed. A copy of the FCS\nAgreement is provided herein under Exhibit 10.1.\n\n \n\nOn July 6, 2026, we issued 22,342 Series\nB Preferred shares (subscription payable) for 2,3125,000 Series B Preferred shares and 51 Series M Preferred shares of Himalaya Technologies,\nInc. (OTC: HMLA) valued at $670,260, making HMLA a majority owned subsidiary. HMLA is owner and operator of Mophoe.com @ https://beta.mophoe.com/,\na crypto social site and trading platform currently under development.\n\n \n\nOn July 6, 2026, we issued 369 Series B Preferred\nshares (subscription payable) to our CEO, Vikram Grover, for a software platform that enables the creation of niche social networks including\nKanab Club @ https://www.kanab.club/. We intend to use the code to enhance Mophoe.com and deploy additional communities in the future.\nThe transaction was valued at $11,069.\n\n \n\n 2 \n\n \n\n \n\nOn July 14, 2026, our majority owned subsidiary\nHimalaya Technologies, Inc. mutually terminated its previously announced strategic development agreement with a third party and canceled\n9,684,43 Series B Preferred shares representing one half of the Company’s diluted shares outstanding.\n\n \n\nOn July 14, 23026, we added Richard Fetyko,\nCEO of altFINS, j.s.a. (“altFINS”), a crypto analytics and trading platform @ https://altfins.com/ to our Advisory Board granting\nhim up to 300,000 stock options over three years with an initial tranche of 100,000 common stock purchase warrants struck at $0.03 subject\nto certain adjustments. We intend to add altFINS’ AI driven capabilities to our recently announced Digital Asset Treasury 2.0 (DAT\n2.0) to provide excess alpha versus monolithic first generation DAT companies. To this end, we signed a letter of intent (LOI) with altFINS\nto partner and cross-invest in each of our Companies, including a planned issuance to altFINS of 2,500,000 common share equivalents (“CSE’s)\nin return for an option to buy up to 22% of altFINS equity capitalization for two million euros. We intend to move to definitive agreement\nin the next month. A copy of the LOI is provided herein under Exhibit 10.2.\n\n \n\nAbout Farrington Capital Group, LLC:\n\n \n\nFarrington Capital Group, LLC (“FCG”)\nis a private investment, development, and cognitive holding company that specializes in deploying advanced technology layers across high-impact,\nessential industries. Led by Founder and Managing Director Alfred Farrington II, FCG integrates its proprietary “Intelligence OS”\n- a technological ecosystem leveraging applied artificial intelligence and blockchain-verified ledgers—to automate operational workflows\nand maximize scaling efficiencies across its core portfolio entities. Strategically focused on asset classes within federally designated\nQualified Opportunity Zones, the firm operates at the modern convergence of educational technology, bio-informatics, and localized digital\ninfrastructure. Through its targeted capital allocation models and deep executive leadership, FCG acts as a modern venture builder, driving\nsystemic economic development, localized digital access, and high-margin compounding equity growth.\n\n \n\nAbout Richard Fetyko:\n\n \n\nRichard Fetyko is the founder and CEO of\naltFINS, a crypto analytics and education platform. A 14-year Wall Street veteran, he worked as an equity research analyst at firms including\nJanney Montgomery Scott and as a portfolio manager at Twin Capital before founding altFINS in 2020 to bring professional-grade analytical\ntools to crypto traders. He holds an MBA in Finance from the University of Oklahoma.\n\n \n\nAbout altFINS, j.s.a.:\n\n \n\naltFINS is a crypto analytics and education\nplatform used by traders worldwide, from beginners to experts, who value data-driven insights over market hype. The platform scans 2,000+\ncoins across 150 technical indicators, multiple time intervals, and on-chain metrics to deliver automated market insights. Combined with\nAI-detected chart patterns, AI trade setups, and expert-vetted analyses, altFINS helps traders find ideas, create alerts, execute strategies,\nand monitor portfolio performance across exchanges, turning market noise into confident trading decisions. In 2026, altFINS is expanding\nbeyond crypto to bring its screening and analysis tools to stocks and forex markets.\n\n \n\n**Exhibit No. Description**\n\n \n\n10.1 [Bio-Path Holdings, Inc. – Farrington Capital Group, LLC Agreement – 07/03/2026](ex10_1.htm)\n\n10.2 [Bio-Path Holdings, Inc. – altFINS, j.s.a. LOI – 07/14/2026](ex10_2.htm)\n\n104 Cover Page Interactive Data File (embedded\nwithin the Inline XBRL document)\n\n 3 \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements\nof the Securities Exchange Act of 1934, the Company has duly caused this Current Report to be signed on its behalf by the undersigned\nhereunto duly authorized.\n\n \n\n \n**BIO-PATH HOLDINGS, INC.**\n\n \n \n\nDated:\nJuly 16, 2026 \nBy:\n/s/ Vikram Grover\n\n \n \nVikram Grover\n\n \n \nChief Executive Officer, Chief Financial Officer and Director\n\n \n\n 4"}